Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,087,105
-$8,012,182 QoQ
Shares Held
1,268,147
-59.5% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#21
of 175 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Derivatives in ABUS
reported options exposure · as of Dec 31, 2023CallValue
$444,250
CallShares
177,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. ABUS ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in ABUS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,087,105 | 1,268,147 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,099,287 | 3,133,175 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $26,046,674 | 5,415,109 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $13,180,646 | 2,903,226 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,731,638 | 2,825,773 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,558,107 | 1,879,114 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,084,202 | 1,554,802 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,043,885 | 2,089,321 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,163,813 | 3,289,260 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,351,392 | 2,074,183 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,672,060 | 3,468,824 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $444,250 | 177,700 | Call | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||